The nuclear receptor PPARα is activated by drugs used to decrease heart disease risk by improving circulating lipids. New findings indicate that PPARα may decrease vascular disease by promoting the activity of a tumor suppressor in smooth muscle cells, a surprising mechanism since PPARα causes tumors in rodents.

Original languageEnglish
Pages (from-to)341-342
Number of pages2
JournalCell metabolism
Issue number6
StatePublished - Dec 2005


Dive into the research topics of 'PPARα: Savior or savage?'. Together they form a unique fingerprint.

Cite this